2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents

被引:23
|
作者
Gupta, MK [1 ]
Mishra, P [1 ]
Prathipati, P [1 ]
Saxena, AK [1 ]
机构
[1] Cent Drug Res Inst, Div Med Chem, Lucknow 226001, Uttar Pradesh, India
关键词
D O I
10.1016/S0968-0896(02)00421-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide deformylase catalyzes the removal of N-formyl group from the N-formylmethionine of ribosome synthesized polypeptide in eubacteria. Quantitative structure-activity relationship (QSAR) studies have been carried out in a series of beta-sulfonyl and beta-sulfinyl hydroxamic acid derivatives for their PDF enzyme inhibitory and antibacterial activities against Escherichia coli DC2 and Moraxella catarrhalis RA21 which demonstrate that the PDF inhibitory activity in cell free and whole cell system increases with increase in molar refractivity and hydrophobicity. The comparison of the QSARs between the cell free and whole cell system indicate that the active binding sites in PDF isolated from E. coli and in M. catarrhalis RA21 are similar and the whole cell antibacterial activity is mainly due to the inhibition of PDF. Apart from this the QSARs on some matrixmetelloproteins (COL-1. COL-3, MAT and HME) and natural endopeptidase (NEP) indicate the possibilities of introducing selectivity in these hydroxamic acid derivatives for their PDF inhibitory activity. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3713 / 3716
页数:4
相关论文
共 50 条
  • [21] Synthesis, characterization, antibacterial evaluation, 2D-QSAR modeling and molecular docking studies for benzocaine derivatives
    Israa Taha
    Eman M. Keshk
    Abdel-Galil M. Khalil
    Ahmed Fekri
    Molecular Diversity, 2021, 25 : 435 - 459
  • [22] Synthesis, characterization, antibacterial evaluation, 2D-QSAR modeling and molecular docking studies for benzocaine derivatives
    Taha, Israa
    Keshk, Eman M.
    Khalil, Abdel-Galil M.
    Fekri, Ahmed
    MOLECULAR DIVERSITY, 2021, 25 (01) : 435 - 459
  • [23] Peptide deformylase inhibitors as potent antimycobacterial agents
    Teo, Jeanette W. P.
    Thayalan, Pamela
    Beer, David
    Yap, Amelia S. L.
    Nanjundappa, Mahesh
    Ngew, Xinyi
    Duraiswamy, Jeyaraj
    Liung, Sarah
    Dartois, Veronique
    Schreiber, Mark
    Hasan, Samiul
    Cynamon, Michael
    Ryder, Neil S.
    Yang, Xia
    Weidmann, Beat
    Bracken, Kathryn
    Dick, Thomas
    Mukherjee, Kakoli
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3665 - 3673
  • [24] Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase
    Grant, SK
    Green, BG
    Kozarich, JW
    BIOORGANIC CHEMISTRY, 2001, 29 (04) : 211 - 222
  • [25] Synthesis and 4D-QSAR Studies of Alanine Hydroxamic Acid Derivatives as Aminopeptidase N Inhibitors
    Gao, Min
    Lv, QiaoLi
    Zhang, HouPan
    Tu, GuoGang
    MEDICINAL CHEMISTRY, 2021, 17 (06) : 658 - 666
  • [26] Cytotoxic Evaluation, Molecular Docking, and 2D-QSAR Studies of Dihydropyrimidinone Derivatives as Potential Anticancer Agents
    Altaf, Reem
    Nadeem, Humaira
    Ilyas, Umair
    Iqbal, Jamshed
    Paracha, Rehan Zafar
    Zafar, Hajra
    Paiva-Santos, Ana Claudia
    Sulaiman, Muhammad
    Raza, Faisal
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [27] 3D-QSAR of sulfonamide hydroxamic acid HDAC inhibitors
    Liu, B
    Lu, AJ
    Liao, CZ
    Liu, HB
    Zhou, JJ
    ACTA PHYSICO-CHIMICA SINICA, 2005, 21 (03) : 333 - 337
  • [28] 2D-QSAR study of fullerene nanostructure derivatives as potent HIV-1 protease inhibitors
    Barzegar, Abolfazl
    Mousavi, Somaye Jafari
    Hamidi, Hossein
    Sadeghi, Mehdi
    PHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES, 2017, 93 : 324 - 331
  • [29] Ferulic Hydroxamic Acid Triazole Hybrids as Peptide Deformylase Inhibitors: Synthesis, Molecular Modelling and Biological Evaluation
    Aneja, Babita
    Khan, Parvez
    Alam, Shadab
    Hasan, Phool
    Abid, Mohammad
    CHEMISTRYSELECT, 2020, 5 (37): : 11420 - 11430
  • [30] Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition
    Thorarensen, A
    Douglas, MR
    Rohrer, DC
    Vosters, AF
    Yem, AW
    Marshall, VD
    Lynn, JC
    Bohanon, MJ
    Tomich, PK
    Zurenko, GE
    Sweeney, MT
    Jensen, RM
    Nielsen, JW
    Seest, EP
    Dolak, LA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (11) : 1355 - 1358